Keyphrases
Lung Transplantation
96%
Lung
68%
Asthma
63%
Ventilator-associated Pneumonia
49%
Confidence Interval
44%
Intensive Care Unit
40%
COVID-19
35%
Pulmonary Arterial Hypertension
29%
Clinical Outcomes
27%
Airway
26%
Pulmonary Embolism
26%
Severe Asthma
25%
Sepsis
23%
Chronic Obstructive Pulmonary Disease
23%
Pneumonia
23%
Mechanical Ventilation
22%
Airway Epithelial Cells
22%
Critically Ill Patients
20%
Risk Factors
20%
Hospitalization
19%
Cystic Fibrosis
19%
Transplantation
19%
Antibiotics
18%
Hospital Mortality
18%
Emphysema
18%
Bronchiolitis Obliterans Syndrome
18%
Odds Ratio
18%
Acute Rejection
17%
Forced Expiratory Volume in 1 Second (FEV1)
17%
T Cells
17%
Inflammation
17%
Clinical Trials
16%
Septic Shock
16%
Acute Respiratory Distress Syndrome
16%
United States
16%
Pulmonary Hypertension
16%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Community-acquired Pneumonia
16%
Macrophages
15%
CD28
15%
Lung Volume Reduction Surgery
15%
Placebo
15%
Methicillin-resistant Staphylococcus Aureus
14%
Acute Pulmonary Embolism
14%
Adjusted Odds Ratio
14%
High Risk
13%
Emergency Department
13%
Epithelial Cells
13%
Mechanically Ventilated Patients
13%
Gene Expression
13%
Nosocomial Pneumonia
13%
Neutrophils
13%
Lung Function
13%
Symptomatic Pulmonary Embolism
12%
Antimicrobial Therapy
12%
Patient Outcomes
12%
Acute Symptoms
12%
Randomized Controlled Trial
12%
Hospitalized Patients
12%
Severe Sepsis
11%
Virus
11%
Idiopathic Pulmonary Fibrosis
11%
Immune Response
11%
Retrospective Cohort Study
11%
Chronic Lung Allograft Dysfunction
10%
Surgical Intensive Care Unit
10%
Mouse Model
10%
Meta-analysis
10%
Bronchial Thermoplasty
10%
Epidemiology
10%
Disease Severity
10%
Respiratory Viral Infection
10%
Adult Patients
10%
Healthcare-associated Pneumonia
10%
Bronchoscopy
10%
Severe Asthma Research Program
9%
Acute Lung Injury
9%
Length of Hospital Stay
9%
Inhaled Corticosteroids
9%
Human Lung
9%
Randomized Trial
9%
Asthma Control
9%
Quality of Life
9%
Viral Infection
9%
Autophagy
9%
Asthmatic
8%
Bloodstream Infection
8%
Nosocomial Infection
8%
FOXJ1
8%
All-cause Mortality
8%
Bronchoalveolar Lavage
8%
Airway Disease
8%
Interleukin-13 (IL-13)
8%
Airway Inflammation
8%
Innate Immune Response
8%
Computed Tomography
8%
Antimicrobial Resistance
8%
Critical Care
8%
Jewish
8%
Primary Graft Dysfunction
8%
Medicine and Dentistry
Lung
100%
Lung Transplantation
82%
Asthma
47%
Infection
38%
Intensive Care Unit
37%
Diseases
35%
Pulmonary Embolism
32%
Pulmonary Hypertension
31%
COVID-19
31%
Sepsis
24%
Ventilator-Associated Pneumonia
23%
Chronic Obstructive Pulmonary Disease
23%
Artificial Respiration
21%
Odds Ratio
19%
Diagnosis
19%
Emphysema
18%
Pathogen
17%
Pneumonectomy
17%
Allograft
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Epithelial Cell
15%
Cystic Fibrosis
14%
Bronchiolitis Obliterans
14%
Transplantation
14%
Acute Pulmonary Embolism
13%
Intensive Care
13%
Bronchoscopy
13%
Placebo
13%
Antibiotics
13%
Severe Asthma
12%
Quality of Life
12%
Clinical Trial
12%
Hospital Mortality
12%
Emergency Department
11%
Cohort Analysis
11%
Antibiotic Therapy
11%
Septic Shock
11%
Airway Epithelial Cell
10%
Health Care Cost
10%
Biopsy Technique
10%
Acute Respiratory Distress Syndrome
10%
Clinician
10%
Bronchial Thermoplasty
9%
Bloodstream Infection
9%
Retrospective Cohort Study
9%
Antibiotic Resistance
9%
Endobronchial Ultrasonography
9%
Silo-Filler's Disease
9%
Acute Graft Rejection
9%
Adverse Event
9%
Antiinfective Agent
8%
Macrophage
8%
Randomized Controlled Trial
8%
Computer Assisted Tomography
8%
Idiopathic Pulmonary Fibrosis
8%
Cohort Effect
8%
Biological Marker
8%
Prevalence
8%
Respiratory Disease
8%
Immune Response
8%
Forced Expiratory Volume
7%
In Vitro
7%
T Cell
7%
Lung Volume
7%
Heart Transplantation
7%
Dyspnea
7%
Combination Therapy
7%
Antibody Mediated Rejection
7%
Immunity
7%
Chronic Graft Rejection
7%
Antimicrobial Therapy
7%
Virus
7%
Community-Acquired Pneumonia
7%
Hospital-Acquired Pneumonia
7%
Methicillin Resistant Staphylococcus Aureus
7%
Logistic Regression Analysis
6%
Meta-Analysis
6%
Patient with Asthma
6%
Health Care
6%
Primary Graft Dysfunction
6%
Risk Stratification
6%
Neutrophil
6%
Peripheral Lung Lesion
6%
Immunosuppressive Treatment
6%
Lung Nodule
6%
Hazard Ratio
6%
All Cause Mortality
6%
Health Care Associated Pneumonia
6%
Endothelial Cell
6%
Pseudomonas aeruginosa
6%
Hospital Infection
6%
Comorbidity
6%
Receptor
5%
Systematic Review
5%
Acute Lung Injury
5%
Lung Graft Rejection
5%
Gene Expression
5%
Pneumonia
5%
Outpatient
5%
Lung Lavage
5%